Insider Trades103 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 1,419 | $209.28 | $20.5B | -21.78% | +8.00% | $297.0K | -3.87% | — | Sell Now |
| Jun 4, 2026 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 65 | $212.24 | $20.5B | -21.78% | +8.00% | $13.8K | -1.04% | — | Sell Now |
| Jun 4, 2026 | Sell | STE | Karen L Burton | Sr. Vice Pres., CFO | 90 | $212.24 | $20.5B | -21.78% | +8.00% | $19.1K | -0.68% | — | Sell Now |
| Jun 4, 2026 | Sell | STE | Kenneth E Kohler | SVP & GM, AST | 150 | $212.24 | $20.5B | -21.78% | +8.00% | $31.8K | -1.31% | — | Sell Now |
| Jun 4, 2026 | Sell | STE | Julia Madsen | Sr. VP and GM, Life Sciences | 195 | $212.24 | $20.5B | -21.78% | +8.00% | $41.4K | -1.57% | — | Sell Now |
| Jun 4, 2026 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 401 | $212.24 | $20.5B | -21.78% | +8.00% | $85.1K | -1.08% | — | Sell Now |
| Jun 4, 2026 | Sell | STE | Mary Clare Fraser | SVP & Chief HRO | 600 | $212.24 | $20.5B | -21.78% | +8.00% | $127.3K | -4.19% | — | Sell Now |
| Jun 4, 2026 | Sell | STE | Daniel A Carestio | President and CEO | 6,317 | $213.35 | $20.5B | -21.78% | +8.00% | $1.3M | -3.11% | — | Sell Now |
| Jun 3, 2026 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 64 | $210.19 | $20.5B | -21.78% | +8.00% | $13.5K | -1.01% | — | Sell Now |
| Jun 3, 2026 | Sell | STE | Kenneth E Kohler | SVP & GM, AST | 184 | $210.19 | $20.5B | -21.78% | +8.00% | $38.7K | -1.58% | — | Sell Now |
| Jun 3, 2026 | Sell | STE | Karen L Burton | Sr. Vice Pres., CFO | 190 | $210.19 | $20.5B | -21.78% | +8.00% | $39.9K | -1.41% | — | Sell Now |
| Jun 3, 2026 | Sell | STE | Julia Madsen | Sr. VP and GM, Life Sciences | 239 | $210.19 | $20.5B | -21.78% | +8.00% | $50.2K | -1.88% | — | Sell Now |
| Jun 3, 2026 | Sell | STE | Mary Clare Fraser | SVP & Chief HRO | 311 | $210.19 | $20.5B | -21.78% | +8.00% | $65.4K | -2.13% | — | Sell Now |
| Jun 3, 2026 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 365 | $210.19 | $20.5B | -21.78% | +8.00% | $76.7K | -0.97% | — | Sell Now |
| Jun 3, 2026 | Sell | STE | Daniel A Carestio | President and CEO | 2,619 | $210.19 | $20.5B | -21.78% | +8.00% | $550.5K | -3.61% | — | Sell Now |
| Jun 2, 2026 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 41 | $209.76 | $20.5B | -21.78% | +8.00% | $8.6K | -0.46% | — | Sell Now |
| Jun 2, 2026 | Buy | STE | Karen L Burton | Sr. Vice Pres., CFO | 66 | $209.76 | $20.5B | -21.78% | +8.00% | $13.8K | +0.21% | — | Sell Now |
| Jun 2, 2026 | Sell | STE | Kenneth E Kohler | SVP & GM, AST | 66 | $209.76 | $20.5B | -21.78% | +8.00% | $13.8K | -0.34% | — | Sell Now |
| Jun 2, 2026 | Sell | STE | Cary L Majors | SVP and President, Healthcare | 67 | $209.76 | $20.5B | -21.78% | +8.00% | $14.1K | -0.20% | — | Sell Now |
| Jun 2, 2026 | Sell | STE | Julia Madsen | Sr. VP and GM, Life Sciences | 127 | $209.76 | $20.5B | -21.78% | +8.00% | $26.6K | -0.61% | — | Sell Now |
| Jun 2, 2026 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 247 | $209.76 | $20.5B | -21.78% | +8.00% | $51.8K | -0.47% | — | Sell Now |
| Jun 2, 2026 | Sell | STE | Lindsey Mcgowan | VP, Chf. Comp. & Quality Offc. | 329 | $209.76 | $20.5B | -21.78% | +8.00% | $69.0K | -3.28% | — | Sell Now |
| Jun 2, 2026 | Sell | STE | Mary Clare Fraser | SVP & Chief HRO | 591 | $209.76 | $20.5B | -21.78% | +8.00% | $124.0K | -2.30% | — | Sell Now |
| Jun 2, 2026 | Sell | STE | Daniel A Carestio | President and CEO | 995 | $209.76 | $20.5B | -21.78% | +8.00% | $208.7K | -0.64% | — | Sell Now |
| Jun 1, 2026 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 81 | $211.07 | $20.5B | -21.78% | +8.00% | $17.1K | -1.42% | — | Sell Now |
| Jun 1, 2026 | Sell | STE | Karen L Burton | Sr. Vice Pres., CFO | 99 | $211.07 | $20.5B | -21.78% | +8.00% | $20.9K | -1.19% | — | Sell Now |
| Jun 1, 2026 | Sell | STE | Kenneth E Kohler | SVP & GM, AST | 109 | $211.07 | $20.5B | -21.78% | +8.00% | $23.0K | -1.13% | — | Sell Now |
| Jun 1, 2026 | Sell | STE | Lindsey Mcgowan | VP, Chf. Comp. & Quality Offc. | 198 | $211.07 | $20.5B | -21.78% | +8.00% | $41.8K | -3.94% | — | Sell Now |
| Jun 1, 2026 | Sell | STE | Julia Madsen | Sr. VP and GM, Life Sciences | 208 | $211.07 | $20.5B | -21.78% | +8.00% | $43.9K | -1.94% | — | Sell Now |
| Jun 1, 2026 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 337 | $211.07 | $20.5B | -21.78% | +8.00% | $71.1K | -1.00% | — | Sell Now |
| Jun 1, 2026 | Sell | STE | Mary Clare Fraser | SVP & Chief HRO | 673 | $211.07 | $20.5B | -21.78% | +8.00% | $142.1K | -5.22% | — | Sell Now |
| Jun 1, 2026 | Sell | STE | Cary L Majors | SVP and President, Healthcare | 768 | $211.07 | $20.5B | -21.78% | +8.00% | $162.1K | -5.72% | — | Sell Now |
| Jun 1, 2026 | Sell | STE | Daniel A Carestio | President and CEO | 1,254 | $211.07 | $20.5B | -21.78% | +8.00% | $264.7K | -2.45% | — | Sell Now |
| Nov 21, 2025 | Sell | STE | Julia Madsen | Sr. VP and GM, Life Sciences | 10,016 | $195.11 | $20.5B | -21.78% | +8.00% | $2.0M | +0.00% | — | Sell Now |
| Nov 18, 2025 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 8,572 | $226.48 | $20.5B | -21.78% | +8.00% | $1.9M | -4.61% | — | Sell Now |
| Nov 11, 2025 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 30,000 | $167.43 | $20.5B | -21.78% | +8.00% | $5.0M | +0.00% | — | Sell Now |
| Oct 6, 2025 | Sell | STE | Daniel A Carestio | President and CEO | 159 | $241.82 | $20.5B | -21.78% | +8.00% | $38.4K | -0.31% | — | Sell Now |
| Oct 1, 2025 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 26 | $241.30 | $20.5B | -21.78% | +8.00% | $6.3K | -0.36% | — | Sell Now |
| Oct 1, 2025 | Sell | STE | Karen L Burton | Sr. Vice Pres., CFO | 39 | $241.30 | $20.5B | -21.78% | +8.00% | $9.4K | -0.27% | — | Sell Now |
| Oct 1, 2025 | Sell | STE | Julia Madsen | Sr. VP and GM, Life Sciences | 52 | $241.30 | $20.5B | -21.78% | +8.00% | $12.5K | -0.48% | — | Sell Now |
| Oct 1, 2025 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 91 | $241.30 | $20.5B | -21.78% | +8.00% | $22.0K | -0.27% | — | Sell Now |
| Oct 1, 2025 | Sell | STE | Daniel A Carestio | President and CEO | 130 | $241.30 | $20.5B | -21.78% | +8.00% | $31.4K | -0.25% | — | Sell Now |
| Oct 1, 2025 | Sell | STE | Mary Clare Fraser | SVP & Chief HRO | 207 | $241.30 | $20.5B | -21.78% | +8.00% | $49.9K | -1.58% | — | Sell Now |
| Oct 1, 2025 | Sell | STE | Cary L Majors | SVP and President, Healthcare | 303 | $241.30 | $20.5B | -21.78% | +8.00% | $73.1K | -2.21% | — | Sell Now |
| Aug 20, 2025 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 6,408 | $198.15 | $20.5B | -21.78% | +8.00% | $1.3M | +0.00% | — | Sell Now |
| Aug 11, 2025 | Sell | STE | Karen L Burton | VP & CAO | 15,800 | $177.97 | $20.5B | -21.78% | +8.00% | $2.8M | +0.00% | — | Sell Now |
| Jun 13, 2025 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 1,978 | $241.45 | $20.5B | -21.78% | +8.00% | $477.6K | -2.78% | — | Sell Now |
| Jun 4, 2025 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 66 | $242.10 | $20.5B | -21.78% | +8.00% | $16.0K | -0.91% | — | Sell Now |
| Jun 4, 2025 | Sell | STE | Karen L Burton | VP & CAO | 92 | $242.10 | $20.5B | -21.78% | +8.00% | $22.3K | -1.51% | — | Sell Now |
| Jun 4, 2025 | Sell | STE | Kenneth E Kohler | SVP & GM, AST | 154 | $242.10 | $20.5B | -21.78% | +8.00% | $37.3K | -2.22% | — | Sell Now |
| Jun 4, 2025 | Sell | STE | Julia Madsen | Sr. VP and GM, Life Sciences | 194 | $242.10 | $20.5B | -21.78% | +8.00% | $47.0K | -1.77% | — | Sell Now |
| Jun 4, 2025 | Sell | STE | Michael J Tokich | Sr. Vice Pres., CFO | 341 | $242.10 | $20.5B | -21.78% | +8.00% | $82.6K | -0.77% | — | Sell Now |
| Jun 4, 2025 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 425 | $242.10 | $20.5B | -21.78% | +8.00% | $102.9K | -1.18% | — | Sell Now |
| Jun 4, 2025 | Sell | STE | Daniel A Carestio | President and CEO | 19,547 | $242.51 | $20.5B | -21.78% | +8.00% | $4.7M | -7.58% | — | Sell Now |
| Jun 2, 2025 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 165 | $242.08 | $20.5B | -21.78% | +8.00% | $39.9K | -0.82% | — | Sell Now |
| Jun 2, 2025 | Sell | STE | Kenneth E Kohler | SVP & GM, AST | 219 | $242.08 | $20.5B | -21.78% | +8.00% | $53.0K | -1.41% | — | Sell Now |
| Jun 2, 2025 | Sell | STE | Karen L Burton | VP & CAO | 229 | $242.08 | $20.5B | -21.78% | +8.00% | $55.4K | -1.79% | — | Sell Now |
| Jun 2, 2025 | Sell | STE | Julia Madsen | Sr. VP and GM, Life Sciences | 463 | $242.08 | $20.5B | -21.78% | +8.00% | $112.1K | -1.67% | — | Sell Now |
| Jun 2, 2025 | Sell | STE | Mary Clare Fraser | SVP & Chief HRO | 548 | $242.08 | $20.5B | -21.78% | +8.00% | $132.7K | -4.92% | — | Sell Now |
| Jun 2, 2025 | Sell | STE | Cary L Majors | SVP and President, Healthcare | 564 | $242.08 | $20.5B | -21.78% | +8.00% | $136.5K | -4.96% | — | Sell Now |
| Jun 2, 2025 | Sell | STE | Michael J Tokich | Sr. Vice Pres., CFO | 727 | $242.08 | $20.5B | -21.78% | +8.00% | $176.0K | -0.57% | — | Sell Now |
| Jun 2, 2025 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 844 | $242.08 | $20.5B | -21.78% | +8.00% | $204.3K | -0.85% | — | Sell Now |
| Jun 2, 2025 | Sell | STE | Daniel A Carestio | President and CEO | 3,065 | $242.08 | $20.5B | -21.78% | +8.00% | $742.0K | -1.87% | — | Sell Now |
| May 20, 2025 | Sell | STE | Cary L Majors | SVP and President, Healthcare | 25,656 | $198.56 | $20.5B | -21.78% | +8.00% | $5.1M | +0.00% | — | Sell Now |
| Nov 25, 2024 | Sell | STE | Cary L Majors | SVP and President, Healthcare | 1,682 | $217.32 | $20.5B | -21.78% | +8.00% | $365.5K | -12.88% | — | Sell Now |
| Oct 1, 2024 | Sell | STE | Karen L Burton | VP & CAO | 26 | $235.78 | $20.5B | -21.78% | +8.00% | $6.1K | -0.59% | — | Sell Now |
| Oct 1, 2024 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 78 | $235.78 | $20.5B | -21.78% | +8.00% | $18.4K | -1.13% | — | Sell Now |
| Oct 1, 2024 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 91 | $235.78 | $20.5B | -21.78% | +8.00% | $21.5K | -0.27% | — | Sell Now |
| Oct 1, 2024 | Sell | STE | Daniel A Carestio | President and CEO | 130 | $235.78 | $20.5B | -21.78% | +8.00% | $30.7K | -0.23% | — | Sell Now |
| Oct 1, 2024 | Sell | STE | Michael J Tokich | Sr. Vice Pres., CFO | 194 | $235.78 | $20.5B | -21.78% | +8.00% | $45.7K | -0.45% | — | Sell Now |
| Oct 1, 2024 | Sell | STE | Julia Madsen | Sr. VP and GM, Life Sciences | 250 | $235.78 | $20.5B | -21.78% | +8.00% | $58.9K | -2.59% | — | Sell Now |
| Sep 13, 2024 | Sell | STE | Michael J Tokich | Sr. Vice Pres., CFO | 46,664 | $179.57 | $20.5B | -21.78% | +8.00% | $8.4M | +0.00% | — | Sell Now |
| Sep 10, 2024 | Sell | STE | Michael J Tokich | Sr. Vice Pres., CFO | 46,664 | $180.61 | $20.5B | -21.78% | +8.00% | $8.4M | +0.00% | — | Sell Now |
| Jun 5, 2024 | Sell | STE | Julia Madsen | Senior VP, Life Sciences | 7,304 | $153.13 | $20.5B | -21.78% | +8.00% | $1.1M | +0.00% | — | Sell Now |
| Jun 5, 2024 | Sell | STE | Cary L Majors | SVP and President, Healthcare | 9,864 | $171.92 | $20.5B | -21.78% | +8.00% | $1.7M | +0.00% | — | Sell Now |
| Jun 3, 2024 | Sell | STE | Kenneth E Kohler | SVP & GM, AST | 154 | $228.37 | $20.5B | -21.78% | +8.00% | $35.2K | -2.50% | — | Sell Now |
| Jun 3, 2024 | Sell | STE | Karen L Burton | VP & CAO | 187 | $228.37 | $20.5B | -21.78% | +8.00% | $42.7K | -1.73% | — | Sell Now |
| Jun 3, 2024 | Sell | STE | Mary Clare Fraser | SVP & Chief HRO | 236 | $228.37 | $20.5B | -21.78% | +8.00% | $53.9K | -2.53% | — | Sell Now |
| Jun 3, 2024 | Sell | STE | Julia Madsen | Senior VP, Life Sciences | 299 | $228.37 | $20.5B | -21.78% | +8.00% | $68.3K | -1.20% | — | Sell Now |
| Jun 3, 2024 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 389 | $228.37 | $20.5B | -21.78% | +8.00% | $88.8K | -2.01% | — | Sell Now |
| Jun 3, 2024 | Sell | STE | Cary L Majors | SVP and President, Healthcare | 694 | $228.37 | $20.5B | -21.78% | +8.00% | $158.5K | -6.10% | — | Sell Now |
| Jun 3, 2024 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 723 | $228.37 | $20.5B | -21.78% | +8.00% | $165.1K | -0.81% | — | Sell Now |
| Jun 3, 2024 | Sell | STE | Daniel A Carestio | President and CEO | 2,223 | $228.37 | $20.5B | -21.78% | +8.00% | $507.7K | -1.64% | — | Sell Now |
| Jun 3, 2024 | Sell | STE | Michael J Tokich | Sr. Vice Pres., CFO | 2,377 | $228.37 | $20.5B | -21.78% | +8.00% | $542.8K | -1.94% | — | Sell Now |
| May 31, 2024 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 72 | $222.88 | $20.5B | -21.78% | +8.00% | $16.0K | -1.08% | — | Sell Now |
| May 31, 2024 | Sell | STE | Karen L Burton | VP & CAO | 102 | $222.88 | $20.5B | -21.78% | +8.00% | $22.7K | -2.71% | — | Sell Now |
| May 31, 2024 | Sell | STE | Kenneth E Kohler | SVP & GM, AST | 112 | $222.88 | $20.5B | -21.78% | +8.00% | $25.0K | -5.07% | — | Sell Now |
| May 31, 2024 | Sell | STE | Andrew Xilas | SVP and GM, Dental | 124 | $222.88 | $20.5B | -21.78% | +8.00% | $27.6K | -1.92% | — | Sell Now |
| May 31, 2024 | Sell | STE | Julia Madsen | Senior VP, Life Sciences | 207 | $222.88 | $20.5B | -21.78% | +8.00% | $46.1K | -2.42% | — | Sell Now |
| May 31, 2024 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 346 | $222.88 | $20.5B | -21.78% | +8.00% | $77.1K | -1.14% | — | Sell Now |
| May 31, 2024 | Sell | STE | Michael J Tokich | Sr. Vice Pres., CFO | 580 | $222.88 | $20.5B | -21.78% | +8.00% | $129.3K | -1.37% | — | Sell Now |
| May 31, 2024 | Sell | STE | Daniel A Carestio | President and CEO | 1,286 | $222.88 | $20.5B | -21.78% | +8.00% | $286.6K | -2.74% | — | Sell Now |
| May 16, 2024 | Sell | STE | Renato Tamaro | V.P. & Corporate Treasurer | 2,308 | $172.93 | $20.5B | -21.78% | +8.00% | $399.1K | +0.00% | — | Sell Now |
| May 15, 2024 | Sell | STE | Michael J Tokich | Sr. Vice Pres., CFO | 64,000 | $156.23 | $20.5B | -21.78% | +8.00% | $10.0M | +0.00% | — | Sell Now |
| May 14, 2024 | Sell | STE | Karen L Burton | VP & CAO | 3,000 | $235.95 | $20.5B | -21.78% | +8.00% | $707.9K | -44.39% | — | Sell Now |
| May 13, 2024 | Sell | STE | Cary L Majors | SVP and President, Healthcare | 2,024 | $232.13 | $20.5B | -21.78% | +8.00% | $469.8K | -15.11% | — | Sell Now |
| Dec 4, 2023 | Sell | STE | Andrew Xilas | SVP and GM, Dental | 98 | $199.27 | $20.5B | -21.78% | +8.00% | $19.5K | -1.49% | — | Sell Now |
| Oct 9, 2023 | Sell | STE | Andrew Xilas | SVP and GM, Dental | 178 | $225.81 | $20.5B | -21.78% | +8.00% | $40.2K | -2.64% | — | Sell Now |
| Oct 2, 2023 | Sell | STE | Karen L Burton | VP, Controller & CAO | 26 | $215.50 | $20.5B | -21.78% | +8.00% | $5.6K | -0.38% | — | Sell Now |
| Oct 2, 2023 | Sell | STE | John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 61 | $215.50 | $20.5B | -21.78% | +8.00% | $13.1K | -0.20% | — | Sell Now |
| Oct 2, 2023 | Sell | STE | Andrew Xilas | SVP and GM, Dental | 85 | $215.50 | $20.5B | -21.78% | +8.00% | $18.3K | -1.44% | — | Sell Now |
| Oct 2, 2023 | Sell | STE | Daniel A Carestio | President and CEO | 130 | $215.50 | $20.5B | -21.78% | +8.00% | $28.0K | -0.28% | — | Sell Now |
| Oct 2, 2023 | Sell | STE | Julia Madsen | Senior VP, Life Sciences | 171 | $215.50 | $20.5B | -21.78% | +8.00% | $36.9K | -1.96% | — | Sell Now |